Drugs For Immunotherapy Market 2023 : Trends, Business Growth And Major Driving Factors | F. Hoffmann-La Roche Ltd., Novartis AG, Amgen, Inc., AbbVie, Inc., and Merck & Co. Inc., GlaxoSmithKline

The Business Research Company’s Drugs for Immunotherapy Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Drugs for Immunotherapy Global Market Report 2023 evaluates drugs for immunotherapy market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp

The global drugs for immunotherapy market grew from $208.56 billion in 2022 to $231.12 billion in 2023 at a compound annual growth rate (CAGR) of 10.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The drugs for immunotherapy market is expected to grow from $349.53 billion in 2027 at a CAGR of 10.9%.

The drugs for immunotherapy market segments in the report are:

1) By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types

2) By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas

3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users

Top Key players

• Hoffmann-La Roche Ltd.
• Novartis AG
• Amgen, Inc.
• AbbVie, Inc.
• Merck & Co. Inc.

North America was the largest region in the immunotherapy market in 2022.

Get More Information On The Drugs for Immunotherapy Market Report:

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

The table of contents in TBRC’s drugs for immunotherapy market report includes:

1. Executive Summary
2. Drugs for Immunotherapy Market Characteristics
3. Drugs for Immunotherapy Market Trends And Strategies
4. Drugs for Immunotherapy Market – Macro Economic Scenario
5. Drugs for Immunotherapy Market Size And Growth

.

28. Drugs for Immunotherapy Pipeline Analysis
29. Key Mergers And Acquisitions In The Drugs for Immunotherapy Market
30. Drugs for Immunotherapy Market Future Outlook and Potential Analysis
31. Appendix

List Of Tables

Table 1: Global Historic Market Growth, 2017-2022, $ Billion

Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion

Table 3: Global Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Table 4: Global Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Table 5: Global Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

.

Table 65: F. Hoffmann-La Roche Ltd Financial Performance

Table 66: Novartis AG Financial Performance

Table 67: Amgen, Inc Financial Performance

Table 68: AbbVie, Inc Financial Performance

Table 69: Merck & Co., Inc Financial Performance

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model